Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,520
Total Claims
$895K
Drug Cost
529
Beneficiaries
$1,692
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+91%
Opioid rate vs peers
4.3% vs 2.2% avg
+20%
Cost per patient vs peers
$1,692 vs $1,411 avg
+20%
Brand preference vs peers
12.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.3%
Opioid Rate
321
Opioid Claims
$9,630
Opioid Cost
3.7%
Long-Acting Rate
Brand vs Generic
Brand: 949 claims · $743K
Generic: 6,509 claims · $148K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 100 | $122K |
| Semaglutide | 95 | $115K |
| Apixaban | 68 | $67K |
| Empagliflozin | 42 | $59K |
| Tirzepatide | 33 | $46K |
| Rifaximin | 12 | $40K |
| Rivaroxaban | 42 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $27K |
| Dapagliflozin Propanediol | 18 | $24K |
| Semaglutide | 12 | $22K |
| Mirabegron | 32 | $18K |
| Fluticasone/Vilanterol | 25 | $11K |
| Tiotropium Br/Olodaterol Hcl | 14 | $9,590 |
| Insulin Detemir | 12 | $7,873 |
| Estrogens, Conjugated | 13 | $6,743 |
Prescribing Profile
Patient Profile
70
Avg Age
59%
Female
1.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About